Trending: play_arrow pause

play_arrow pause

$AYTU Multiple insights in the last few minutes:

1. ๐Ÿ“œ SEC Form 424B5 filed by Aytu BioScience, Inc.
https://quantisnow.com/insight/965153?s=s
2. ๐Ÿ“œ SEC Form 424B3 filed by Aytu BioScience, Inc.
https://quantisnow.com/insight/965182?s=s

#majorpharmaceuticals #healthcare

$AYTU ๐Ÿ“œ Aytu BioScience, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

https://quantisnow.com/insight/965151?s=s

#majorpharmaceuticals #healthcare

$HARP ๐Ÿ“ƒ Harpoon Therapeutics Provides Progress Update for TriTACยฎ Clinical Programs and ProTriTACโ„ข Platform

https://quantisnow.com/insight/962707?s=s

#healthcare

$HARP ๐Ÿ“œ SEC Form 4: GADICKE ANSBERT sold $1,186,190 worth of Common Stock (57,494 units at $20.63)

https://quantisnow.com/insight/946283?s=s

#healthcare

$BIIB ๐Ÿ“ฐ Biogen and Bio-Thera Announce Positive Results From Phase 3 Study of BAT1806, a Proposed Biosimilar Referencing Actemraยฎ (Tocilizumab)

https://quantisnow.com/insight/914173?s=s

#healthcare

$ZYNE ๐Ÿ“ฐ Zynerba Pharmaceuticals Announces Acceptance of Poster at the 2021 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

https://quantisnow.com/insight/869928?s=s

#majorpharmaceuticals #healthcare

$UNH ๐Ÿ“ฐ United Health Foundation Launches $3 Million Partnership with CAMBA, Inc. to Improve Access to Prenatal Care for Brooklyn's Most Vulnerable Residents

https://quantisnow.com/insight/869198?s=s

#medicalspecialities #healthcare

$BYSI ๐Ÿ“ฐ BeyondSpring Presents Phase 1 Data on the Anti-Cancer Effect of Plinabulin in Combination with Checkpoint Inhibitors in SCLC at the American Society of Clinical Oncology (ASCO) Annual Meeting

https://quantisnow.com/insight/816604?s=s

#healthcare #majorpharmaceuticals

Nothing found!

Sorry, but we could not find anything in our database for your search query {{search_query}}. Please try again by typing other keywords.